Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T01:32:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T21:32:26.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. This is a minor metadata update to the page version.
    Difference
    0.0%
    Check dated 2026-02-12T01:39:51.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Minor page update: Revision from v3.4.0 to v3.4.1 with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:36:19.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    UI changes include showing the glossary option and minor label/versioning updates (e.g., Last Update Submitted that Met QC Criteria vs met QC Criteria; No FEAR Act data vs data) on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T19:50:32.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:56:08.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.